Thursday, October 21, 2010

Progression with Pre- Clinical Studies

With the vision to be a preferred partner by the sponsor in providing complete management to the drug development services; we are working with the unique hallmark of Quality and Innovation. Genelife Clinical Research understands that Pre-Clinical Study is the foremost step to initiate the drug development process.

After playing a significant role in two Clinical studies for US FDA; Genelife has given a fine start with the preclinical Study. We are conducting Ten Pre- Clinical Studies; viz. Acute and Sub Acute studies for the a Inhalation Study, Four intravenous injectable, Five oral formulations. Apart from these Toxicity studies we are also conducting Non-Clinical studies like Capillary Electrophoresis and Stability Study. The Capillary Electrophoresis study we have conducted by Capillary Zone Electrophoresis (CZE). In Capillary Zone Electrophoresis analytes moves in the EOF but separate into bands because of difference in their electrophoretic mobilities. Further to this Capillary Electrophoresis study of a protein molecule. we are looking forward to do conduct another Capillary Electrophoresis of an Alkaloid. Conducting Capillary Electrophoresis study is unique experience as very few CRO's has the capability to conduct Capillary Eletrophorasis study. Now we at Genelife has developed facility for conducting these Studies and will play a vital role in setting up the highest Quality Standard and Expertise.

After these few Pre-Clinical Studies, we have erudite that for perfection one needs experience in the field. We are looking forward for more such preclinical studies and the Clinical Trials of these drugs in near future.

Rahul Bhalla

Clinical Research Associate

No comments:

Post a Comment